Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell (CTC) and other rare cell capture from biological samples. The IsoFlux Rare Cell ...
Lexington, Ky.-based Equine Diagnostic Solutions (EDS) has begun testing for equine rhinitis A virus (ERAV) using a polymerase chain reaction (PCR) testing method. EDS is now one of four labs in the United States offering this test, along ...
Tags: Agriculture, Food
Soligenix, a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, ...
Tags: Soligenix, NIAID, ThermoVax, Drs.John Carpenter
The presence of calf scours is often an unwanted guest during spring calving season. Good management alone is sometimes not enough to protect the calf from scours, and so cattle producers turn to practices like calf vaccination to head ...
Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody ...
Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
Ann Marie Reynolds, a 32-year-old who has been in and out of hospitals fighting chronic kidney disease since she was a teenager, had a less than 1 percent chance of receiving a kidney without the University of Alabama at Birmingham's ...
Tags: chronic kidney disease, incompatible kidney exchange, kidney exchange
Astellas and IBL Concludes Co-Research Agreement Regarding Pharmaceutical Applications of Recombinant Human Proteins Made Using transgenic Silkworms Tokyo, December 25, 2013 - Astellas Pharma Inc. ("Astellas") and Immuno-Biological ...
Scientists say they have the first definitive proof that a deadly respiratory virus in the Middle East infects camels in addition to humans. The finding may help researchers find ways to control the spread of the virus. Using gene ...
Tags: respiratory virus, camels, Middle East respiratory syndrome coronavirus
It's not unusual for people to say they feel much better after dropping gluten from their diets, even though they don't have celiac disease, digestive experts report. What these people describe has come to be called "non-celiac gluten ...
The flu vaccine is less effective for men than women, and researchers at Stanford University believe they've figured out why. The male hormone testosterone causes genes in the immune system to produce fewer antibodies, or defense ...
Tags: flu vaccine, male hormone, testosterone, the immune system, men health
Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux® (cetuximab) product information, updating the indication for Erbitux to the ...
US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...
Temperatures dropped below zero today, and the last hint of green is diminishing from lawns and pastures. Now is a critical time to focus on cows' nutrition. For spring-calving herds, producers need to key in on the needs of the pregnant ...
Tags: Bred Cows, Agriculture, Food
BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...